C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2002
12/31/2002	US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome
12/31/2002	US6500825 Substituted 2-aminoacetamides and the use thereof
12/31/2002	US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
12/31/2002	US6500803 Factor VIIa inhibitors
12/31/2002	US6500503 Cyclohexane derivatives, liquid crystal compositions comprising the same and liquid crystal display devices
12/31/2002	CA2075586C Salicyloyl(thio)ether derivatives, their preparation and intermediates for ther preparation
12/27/2002	WO2002102976A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
12/27/2002	WO2002102793A2 Quinazolinediones as antibacterial agents
12/27/2002	WO2002102783A1 Tyrosine kinase inhibitors
12/27/2002	WO2002102782A2 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE
12/27/2002	WO2002102769A2 Methods for synthesizing substituted pyrimidines
12/27/2002	WO2002102380A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
12/27/2002	WO2002102315A2 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
12/27/2002	WO2002102314A2 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002	WO2002074753A3 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
12/27/2002	WO2002046181A3 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
12/27/2002	CA2753372A1 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
12/27/2002	CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002	CA2450724A1 Quinazoline and pyrido¬2,3-d\|pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002	CA2446963A1 Quinazolinediones as antibacterial agents
12/27/2002	CA2429113A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
12/26/2002	US20020198255 2,4-substituted pyrrolidine derivatives-CCR-3 receptor antagonists
12/26/2002	US20020198236 Small organic molecule regulators of cell proliferation
12/26/2002	US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
12/26/2002	US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa
12/26/2002	US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis
12/26/2002	US20020198173 Viricides for treating HIV and hepatitis virus
12/26/2002	US20020198171 Administering to a hepatitis B infection patient an effective treatment amount of a 2'fluoro- beta -D-nucleoside or salts(containing purine or pyrimidine base)
12/26/2002	US20020195585 Liquid crystalline materials containing perfluoroalkyl and alkenyl tail groups
12/25/2002	CN1387516A Substd. 5-benzyl-2,4-diaminopyrimidines
12/25/2002	CN1387508A N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/25/2002	CN1387087A Color coupler for forming dye, silver halide photosensitive material and azomethine dyes compounds
12/25/2002	CN1097052C Process for production of amidinoindole derivs, and salts thereof
12/24/2002	US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity
12/24/2002	US6498253 Acylated aminophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
12/24/2002	US6498252 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
12/24/2002	US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002	US6498168 Muscarinic antagonists
12/24/2002	US6498164 Such as 1,3-dibenzyl-5-(phenyl- or 2-thienyl-acetyl)barbi-turic acid; malignant hypercalcemia, osteolytic diseases such as paget's disease, osteoporosis, articular rheumatism occurring in knees, shoulders, joints
12/24/2002	US6498163 Pyrido[2,3-D]pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
12/24/2002	US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system
12/24/2002	US6498154 Cyclic regimens using quinazolinone and benzoxazine derivatives
12/24/2002	CA2150812C Catechol diethers as selective pde iv inhibitors
12/19/2002	WO2002100863A1 Corticotropin releasing factor antagonists
12/19/2002	WO2002100838A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002	WO2002100837A1 Process for the preparation of azoxystrobin and analogues thereof
12/19/2002	WO2002100836A2 Compounds, compositions and methods for modulating beta-amyloid production
12/19/2002	WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	WO2002083651A3 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
12/19/2002	WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
12/19/2002	WO2002077254A3 Method for obtaining useful products from organisms
12/19/2002	WO2002070541A3 Peptide deformylase inhibitors
12/19/2002	WO2002063957A3 Selective substituted aryl ketone and safener based herbicides
12/19/2002	US20020193596 Inhibitors of protein isoprenyl transferases
12/19/2002	US20020193377 Quinazolines as MMP-13 inhibitors
12/19/2002	US20020193353 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents
12/19/2002	US20020190250 Iridium complexes in electron transport layer of Light-emitting diodes; bright, efficient, stable; low temperature vacuum deposition and preventing decomposition
12/19/2002	CA2450262A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002	CA2448552A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/18/2002	WO2001097615A2 Herbicidal agent
12/18/2002	EP1267170A1 Method for characterising polypeptides
12/18/2002	EP1266950A1 Lubricant composition containing a triazine molecular complex compound
12/18/2002	EP1265874A2 Method for the simplified production of (3-chloro-4-fluoro-phenyl)- 7-(3-morpholino-4-yl-propoxy)-6-nitro-quinazoline-4-yl]-amine or (3-chloro-4-fluoro-phenyl)- 7-(3-morpholino-4-yl-propoxy)-6-amino-quinazoline-4-yl]-amine
12/18/2002	EP1265866A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
12/18/2002	EP1265861A2 Benzylated pde4 inhibitors
12/18/2002	EP1265850A2 Insecticidal anthranilamides
12/18/2002	EP0843658B1 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
12/18/2002	CN1385423A N-(4,6-disubstituted 6 pyrimidine-2-)aniline and intermediate products preparation pocess thereof
12/18/2002	CN1096454C Process for preparing benzofuranone derivatives
12/18/2002	CN1096446C N-(ortho-substd-benzyloxy)imine derivs, and their use as fungicides, acaricides or insecticides
12/18/2002	CA2417325A1 Herbicidal compositions
12/17/2002	US6495581 Drug for treating diabetes mellitus, hyperlipemia, impaired glucose tolerance, arterial sclerosis and improving insulin resistance, inflammatory disease
12/17/2002	US6495558 Kinase inhibitors
12/17/2002	US6495557 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action
12/17/2002	US6495556 Treating leukemia and lymphoma, sunburn and skin cancer
12/17/2002	US6495554 Phosphodiesterase v inhibitors, treating cardiovascular disorders, and therapy of erectile dysfunction.
12/17/2002	US6495491 Herbicides and insecticides; defoliants, desiccants, haulm killers and especially weed killers
12/17/2002	CA2203389C Bicyclic heterocyclic compounds for the treatment of impotence
12/12/2002	WO2002099124A2 Characterising polypeptides
12/12/2002	WO2002098869A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds
12/12/2002	WO2002098864A1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
12/12/2002	WO2002098854A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002	WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	WO2002098367A2 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity
12/12/2002	WO2002098227A1 Plant growth regulators for cotton hervest
12/12/2002	WO2002064080A3 Matrix metalloproteinase inhibitors
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020188120 Such as 4-(4-methyoxy-benzenesulfonyl)-1-(3-phenyl-propyl)-piperidine-4-carboxylic acid hydroxyamide for treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone diseases, diabetes, and HIV
12/12/2002	US20020188015 Method and composition for rejuvinating cells, tissues organs, hair and nails
12/12/2002	US20020187991 Barbituric acid derivatives
12/12/2002	US20020187989 Preventive or therapeutic drugs for various eosinophilia-related diseases containg chymase inhibitors as the active ingredient
12/12/2002	CA2449942A1 Characterising polypeptides
12/12/2002	CA2449813A1 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002	CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264820A1 Novel amide compounds
12/11/2002	EP1263740A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
12/11/2002	EP1263739A1 Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid
12/11/2002	EP1263738A1 Substituted benzoylcyclohexenones
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists

1 ... 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 ... 427